The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,255.00
Bid: 2,220.00
Ask: 2,290.00
Change: -60.00 (-2.61%)
Spread: 70.00 (3.153%)
Open: 2,295.00
High: 2,240.00
Low: 2,240.00
Prev. Close: 2,300.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

16 Nov 2023 18:10

RNS Number : 7528T
Craneware plc
16 November 2023
 

Craneware plc

 

Result of AGM

 

16 November 2023 - Craneware plc (AIM: CRW.L), the market leader in automated Value Cycle solutions for the US healthcare market, is pleased to announce that at its Annual General Meeting held earlier today, all resolutions were duly passed.

 

The voting results are included below:

 

Resolution

For

Against

Withheld

Total

01

24,840,126

34,685

16,411

24,891,222

02

21,993,109

415,087

2,483,026

24,891,222

03

24,322,850

566,998

1,374

24,891,222

04

24,803,863

87,281

78

24,891,222

05

24,795,020

96,124

78

24,891,222

06

24,804,263

86,881

78

24,891,222

07

18,895,120

5,994,110

1,992

24,891,222

08

24,528,186

362,958

78

24,891,222

09

24,840,898

50,246

78

24,891,222

10

24,852,140

39,004

78

24,891,222

11

24,880,403

10,741

78

24,891,222

12

24,891,162

60

0

24,891,222

13

22,189,067

2,701,525

630

24,891,222

14

24,589,442

301,780

0

24,891,222

15

23,838,081

1,051,288

1,853

24,891,222

16

23,677,229

1,212,135

1,858

24,891,222

17

24,532,189

289,773

69,260

24,891,222

 

Resolution 7

 

The Board of Directors notes that while Resolution 7 was passed and a majority of over 75% of the votes received were 'for' this resolution, a number of the votes received opposed this resolution.

 

Following consultation with shareholders during their voting consideration, the Board identified certain concerns regarding the composition of the Board committees, specifically the Audit and Remuneration committees. As such, it has been agreed that Anne McCune will replace Colleen Blye on these committees with immediate effect. The Board will further consider its composition during the current Fiscal Year.

 

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon

craneware@almastrategic.com

 

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers, Kate Bannatyne

 

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

  

 

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

About Craneware

 

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBIBDBRGBDGXL
Date   Source Headline
9th Nov 20188:55 amRNSDividend Currency Election
7th Nov 201810:42 amRNSResult of AGM
6th Nov 20187:00 amRNSAGM Statement and Capital Markets Day
16th Oct 20187:00 amRNSBlock listing Interim Review
11th Oct 201810:50 amRNSPosting of Annual Report and Notice of AGM
5th Oct 20184:39 pmRNSTotal Voting Rights
5th Oct 20182:55 pmRNSHolding(s) in Company
18th Sep 20182:06 pmRNSSecond Price Monitoring Extn
18th Sep 20182:00 pmRNSPrice Monitoring Extension
11th Sep 201811:10 amRNSHolding(s) in Company
10th Sep 20187:00 amRNSDirector/PDMR Shareholding
7th Sep 201811:40 amRNSHolding(s) in Company
5th Sep 201812:20 pmRNSGrant of Options & Long Term Incentive Plan Awards
4th Sep 20187:00 amRNSFinal Results
1st Aug 20187:00 amRNSAppointment of Joint Broker
10th Jul 20187:00 amRNSTrading Update and Significant Contract Win
17th Apr 20181:55 pmRNSBlock listing Interim Review
12th Apr 20189:54 amRNSHolding(s) in Company
6th Apr 20183:10 pmRNSDividend Currency Election
27th Mar 20181:52 pmRNSHolding(s) in Company
19th Mar 20187:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
14th Mar 20182:11 pmRNSAdditional Listing - Blocklisting of Securities
8th Mar 20187:00 amRNSDirector/PDMR Shareholding
6th Mar 20187:00 amRNSHalf-year Report
16th Feb 201811:53 amRNSHolding(s) in Company
13th Feb 20187:00 amRNSSignificant Contract Wins
31st Jan 20182:59 pmRNSTotal Voting Rights
26th Jan 20182:49 pmRNSHolding(s) in Company
26th Jan 201812:10 pmRNSTotal Voting Rights and Director/PDMR Shareholding
23rd Jan 201812:05 pmRNSResult of Share Buyback
17th Jan 20185:59 pmRNSGrant of Options & Long Term Incentive Plan Awards
16th Jan 20187:00 amRNSShare Buyback
8th Jan 20187:00 amRNSTrading Update and Significant Contract Win
29th Nov 20177:00 amRNSHolding(s) in Company
10th Nov 20171:43 pmRNSDividend Currency Election
8th Nov 20175:00 pmRNSResult of AGM
8th Nov 20177:00 amRNSAGM Statement
31st Oct 20177:00 amRNSSignificant Contract Win
27th Oct 20172:07 pmRNSHolding(s) in Company
18th Oct 20172:06 pmRNSBlock listing Interim Review
12th Oct 201712:15 pmRNSPosting of Annual Report and Notice of AGM
22nd Sep 201712:06 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSFinal Results
11th Jul 20177:00 amRNSTrading Update
5th Apr 20177:00 amRNSHolding(s) in Company
31st Mar 20175:04 pmRNSDividend Currency Election
27th Mar 20176:26 pmRNSGrant of Options & Long Term Incentive Plan Award
23rd Mar 20177:00 amRNSSignificant Contract Win
7th Mar 20177:00 amRNSHalf-year Report
31st Jan 20177:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.